• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Big Pharma Has Mad Love For These 2 Biotechs

cafead

Administrator
Staff member
  • cafead   Oct 11, 2019 at 11:02: PM
via So when I am researching a possible biotech investment, I am happy when I see collaboration. In fact, it's one of the first things I look for on a biotech's website: Right after I check out the company's pipeline, I look to see whether they have any collaborators. RegenXbio (NASDAQ:RGNX) and Denali Therapeutics (NASDAQ:DNLI) are two biotechs that pass my test with flying colors.

article source